Skip to main navigation Skip to search Skip to main content

Adjuvant and Antigen Systems for Malaria Transmission-Blocking Vaccines

  • SUNY Buffalo

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Malaria is transmitted by protozoan parasites of the Plasmodium genus, via mosquito vectors. Highly effective vaccines could be a valuable tool to control the disease, but have remained elusive, in part due to the complex lifecycle of the parasite. Transmission-blocking vaccines (TBVs) take the unconventional approach of targeting the mosquito stages of the parasite life cycle. TBVs are yet to be tested in large-scale human trials, but represent a prominent area of interest for malaria vaccine research and development. Because TBVs rely on passive antibody transfer from a blood meal to the mosquito midgut, techniques to boost host antibody generation are a focus of investigation. In this review, immunostimulants and delivery systems for conjugating, self-assembling, or coadministrating TBV antigens and adjuvants are summarized.

Original languageEnglish
Article number1800011
JournalAdvanced Biosystems
Volume2
Issue number10
DOIs
StatePublished - Oct 2018

Keywords

  • adjuvants
  • antigens
  • malaria
  • transmission-blocking
  • vaccines

Fingerprint

Dive into the research topics of 'Adjuvant and Antigen Systems for Malaria Transmission-Blocking Vaccines'. Together they form a unique fingerprint.

Cite this